1. Home
  2. XENE vs MGEE Comparison

XENE vs MGEE Comparison

Compare XENE & MGEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • MGEE
  • Stock Information
  • Founded
  • XENE 1996
  • MGEE 1855
  • Country
  • XENE Canada
  • MGEE United States
  • Employees
  • XENE N/A
  • MGEE N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • MGEE Electric Utilities: Central
  • Sector
  • XENE Health Care
  • MGEE Energy
  • Exchange
  • XENE Nasdaq
  • MGEE Nasdaq
  • Market Cap
  • XENE 2.9B
  • MGEE 3.0B
  • IPO Year
  • XENE 2014
  • MGEE N/A
  • Fundamental
  • Price
  • XENE $39.36
  • MGEE $83.26
  • Analyst Decision
  • XENE Strong Buy
  • MGEE Sell
  • Analyst Count
  • XENE 11
  • MGEE 2
  • Target Price
  • XENE $52.73
  • MGEE $79.00
  • AVG Volume (30 Days)
  • XENE 747.4K
  • MGEE 146.7K
  • Earning Date
  • XENE 11-11-2025
  • MGEE 11-05-2025
  • Dividend Yield
  • XENE N/A
  • MGEE 2.15%
  • EPS Growth
  • XENE N/A
  • MGEE 12.86
  • EPS
  • XENE N/A
  • MGEE 3.60
  • Revenue
  • XENE $7,500,000.00
  • MGEE $701,317,000.00
  • Revenue This Year
  • XENE N/A
  • MGEE $10.77
  • Revenue Next Year
  • XENE $207.88
  • MGEE $3.48
  • P/E Ratio
  • XENE N/A
  • MGEE $23.22
  • Revenue Growth
  • XENE N/A
  • MGEE 8.61
  • 52 Week Low
  • XENE $26.74
  • MGEE $81.14
  • 52 Week High
  • XENE $46.00
  • MGEE $109.22
  • Technical
  • Relative Strength Index (RSI)
  • XENE 56.70
  • MGEE 47.31
  • Support Level
  • XENE $38.49
  • MGEE $82.36
  • Resistance Level
  • XENE $40.17
  • MGEE $84.44
  • Average True Range (ATR)
  • XENE 1.28
  • MGEE 1.35
  • MACD
  • XENE 0.02
  • MGEE 0.00
  • Stochastic Oscillator
  • XENE 67.55
  • MGEE 62.71

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About MGEE MGE Energy Inc

MGE Energy provides electric service to 161,000 customers and natural gas service to 173,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings.

Share on Social Networks: